Drug recall · October 16, 2019
Optiray 320 recall
Why: Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Optiray 320 (ioversol) Injection 68%, 320 mg/mL Organically Bound Iodine, packaged in 1 - 100 mL Ultraject Prefilled Syringe For Power Injection per carton, RFID Technology, Rx Only, Manufactured by: Liebel-Flarshelm Company, LLC., Raleigh, NC 27616; NDC 0019-1323-00.
- Lots / codes
Lots: L141C, L162A Exp. 06/2021; L146DS, Exp. 05/2021
- Quantity
- 3860 syringes
- Company
- Guerbet LLC, Princeton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- September 13, 2019 · Voluntary: Firm initiated
- Classified
- October 9, 2019
- Reported
- October 16, 2019
- Ended
- October 25, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Iodine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.